Showing results (211-220 of 242) with videos related to

Sort By:
Pageof 25
DEN Open|January 6, 2025
Clinicopathological evaluation of the efficacy of endoscopic treatment for sessile serrated lesions comparing endoscopic mucosal resection, cold snare polypectomy, and underwater endoscopic mucosal resectionKaizo Kagemoto, Koichi Okamoto, Yasuyuki Okada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 10, 2022
Multicenter retrospective study of initial treatment outcome and feasibility of initiating dose reduction of cabozantinib in unresectable hepatocellular carcinomaTetsu Tomonari, Joji Tani, Chikara Ogawa, et al.
Cancer Chemotherapy and Pharmacology|June 26, 2016
Panitumumab in combination with irinotecan plus S-1 (IRIS) as second-line therapy for metastatic colorectal cancerToshi Takaoka, Tetsuo Kimura, Rai Shimoyama, et al.
Cancer Chemotherapy and Pharmacology|December 31, 2009
Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancerYasushi Sato, Tetsuji Takayama, Tamotsu Sagawa, et al.
Cancer Science|July 28, 2020
A randomized, double-blind, placebo-controlled, phase 3 study of tivantinib in Japanese patients with MET-high hepatocellular carcinomaMasatoshi Kudo, Manabu Morimoto, Michihisa Moriguchi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 25, 2016
Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective studyYasushi Sato, Hiroyuki Ohnuma, Takayuki Nobuoka, et al.
International Journal of Hematology|March 29, 2008
Ex vivo large-scale generation of human red blood cells from cord blood CD34+ cells by co-culturing with macrophagesAkihito Fujimi, Takuya Matsunaga, Masayoshi Kobune, et al.
The Lancet. Gastroenterology & Hepatology|April 4, 2021
Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trialHideki Ishikawa, Michihiro Mutoh, Yasushi Sato, et al.
Clinical Colorectal Cancer|September 3, 2018
Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of 2 Randomized Clinical TrialsTakayuki Yoshino, Kentaro Yamazaki, Eiji Shinozaki, et al.
Hepatology International|February 28, 2025
The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in JapanShigeo Shimose, Issei Saeki, Takanori Ito, et al.
Pageof 25